AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2025

Jan 22, 2025

30371_dirs_2025-01-22_8aba9f6d-2d43-40c9-b86b-adf1ce2fd57d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-01-17

Reporting Person: CAGNONI PABLO J (President, R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-17	Employee Stock Option (right to buy)	$71.93	A	40289	Acquired	2035-01-16	Common Stock (40289)	Direct

Footnotes

F1: Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.